JP3124350B2 - Liquid chromatography separation method - Google Patents
Liquid chromatography separation methodInfo
- Publication number
- JP3124350B2 JP3124350B2 JP04001143A JP114392A JP3124350B2 JP 3124350 B2 JP3124350 B2 JP 3124350B2 JP 04001143 A JP04001143 A JP 04001143A JP 114392 A JP114392 A JP 114392A JP 3124350 B2 JP3124350 B2 JP 3124350B2
- Authority
- JP
- Japan
- Prior art keywords
- separation
- mobile phase
- liquid chromatography
- acid
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000926 separation method Methods 0.000 title claims description 27
- 238000004811 liquid chromatography Methods 0.000 title claims description 8
- 150000003839 salts Chemical class 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 15
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 239000005017 polysaccharide Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 18
- 239000000126 substance Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 13
- 230000005526 G1 to G0 transition Effects 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 150000004804 polysaccharides Chemical class 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- 150000001735 carboxylic acids Chemical class 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229960005345 trimebutine Drugs 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 4
- YNPFMWCWRVTGKJ-UHFFFAOYSA-N mianserin hydrochloride Chemical compound [H+].[Cl-].C1C2=CC=CC=C2N2CCN(C)CC2C2=CC=CC=C21 YNPFMWCWRVTGKJ-UHFFFAOYSA-N 0.000 description 4
- 229960004843 mianserin hydrochloride Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- FSRLGULMGJGKGI-BTJKTKAUSA-N Trimebutine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=CC=1C(CC)(N(C)C)COC(=O)C1=CC(OC)=C(OC)C(OC)=C1 FSRLGULMGJGKGI-BTJKTKAUSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- -1 tetraphenylboric acid Chemical compound 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LORDFXWUHHSAQU-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid [2-(dimethylamino)-2-phenylbutyl] ester Chemical compound C=1C=CC=CC=1C(CC)(N(C)C)COC(=O)C1=CC(OC)=C(OC)C(OC)=C1 LORDFXWUHHSAQU-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 239000007848 Bronsted acid Substances 0.000 description 2
- 239000003341 Bronsted base Substances 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- UEQUQVLFIPOEMF-UHFFFAOYSA-N Mianserin Chemical compound C1C2=CC=CC=C2N2CCN(C)CC2C2=CC=CC=C21 UEQUQVLFIPOEMF-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- HFWIMJHBCIGYFH-UHFFFAOYSA-N cyanoform Chemical compound N#CC(C#N)C#N HFWIMJHBCIGYFH-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical group O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- UTSOXZIZVGUTCF-UHFFFAOYSA-N hydrate;hydroiodide Chemical group O.I UTSOXZIZVGUTCF-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960003955 mianserin Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-O oxonium Chemical group [OH3+] XLYOFNOQVPJJNP-UHFFFAOYSA-O 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical group [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 125000005496 phosphonium group Chemical group 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- LPSWFOCTMJQJIS-UHFFFAOYSA-N sulfanium;hydroxide Chemical group [OH-].[SH3+] LPSWFOCTMJQJIS-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium group Chemical group [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、液体クロマトグラフィ
ーにより化合物と化合物を分離する方法に関するもので
あり、研究・製造管理などにおける分析や分取による精
製の目的に用いることができる。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for separating a compound from a compound by liquid chromatography, and can be used for the purpose of purification by analysis or fractionation in research and production control.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】多糖誘
導体あるいはこれをシリカゲルなどの担体に担持した分
離剤は液体クロマトグラフィー用固定相として光学異性
体をはじめとする様々の構造的に類似した化合物(ジア
ステレオマーなどの立体異性体、位置異性体、幾何異性
体、不飽和度の異なる化合物、ホモローグに属する化合
物など)の分離において優れた特性を示すことが明らか
になっている(平成3年1月7日, 第28回HPLC研究談話
会要旨集, p25-26)。この種の固定相には従来主に順相
系移動相、即ち、固定相と移動相の極性を比較した場
合、相対的に極性の高い固定相に対して極性の低い移動
相(代表的なものとしてヘキサンとアルコール類の混合
液)を用いてきた。しかし、分離したい化合物がカルボ
ン酸やアミン等である場合にはピークの形状が異常に巾
広くなる場合などがあり、カルボン酸の分離には酸(例
えば、トリフルオロ酢酸、酢酸、蟻酸など)を、又、ア
ミン類の場合にはアミン(例えば、ジエチルアミン、ト
リエチルアミンなど)を移動相に添加することがピーク
巾を狭くし、分離を良くする効果のあることが明らかに
なっていた。2. Description of the Related Art A polysaccharide derivative or a separating agent in which the polysaccharide derivative is supported on a carrier such as silica gel is used as a stationary phase for liquid chromatography as a variety of structurally similar compounds including optical isomers. (Stereoisomers such as diastereomers, positional isomers, geometric isomers, compounds with different degrees of unsaturation, compounds belonging to homologues, etc.) have been shown to exhibit excellent properties in separation (1991) January 7, 28th HPLC Research Symposium Abstracts, pp. 25-26). Conventionally, this type of stationary phase is mainly composed of a normal phase mobile phase, that is, when the polarities of a stationary phase and a mobile phase are compared, a stationary phase having a relatively high polarity and a mobile phase having a low polarity (typically, Hexane and alcohols). However, when the compound to be separated is a carboxylic acid, an amine, or the like, the peak shape may be unusually wide. For example, an acid (eg, trifluoroacetic acid, acetic acid, formic acid, etc.) may be used to separate the carboxylic acid. In the case of amines, it has been found that adding an amine (eg, diethylamine, triethylamine, etc.) to the mobile phase has the effect of narrowing the peak width and improving the separation.
【0003】しかし分離したい化合物の中には、例えば
スルホン酸などの強酸の塩、グアニジニウムなどの強塩
基の塩、いわゆるオニウム塩(例えば、4級アンモニウ
ム、3級オキソニウム、ホスホニウム、3級スルホニウ
ム等)や両性イオン物質(例えば分子内にアミノ基とカ
ルボキシル基を持つ化合物)においては上に述べたよう
な添加物を用いても効果を示さず、分離が不可能もしく
はピークが著しい変形を示し分離の悪いことが多かっ
た。However, compounds to be separated include, for example, salts of strong acids such as sulfonic acid, salts of strong bases such as guanidinium, so-called onium salts (eg, quaternary ammonium, tertiary oxonium, phosphonium, tertiary sulfonium, etc.). In addition, in the case of zwitterionic substances (for example, compounds having an amino group and a carboxyl group in the molecule), the use of the above-mentioned additives has no effect, and separation is impossible or peaks are significantly deformed and separation is difficult. There were many bad things.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上に述べ
た従来の液体クロマトグラフィー系の問題点を解決する
ために鋭意検討を行い、その結果、順相系移動相中に各
種の塩を添加することによりこれまで分離しにくかった
化合物、あるいは分離できなかった化合物の分離を改善
することができ、よりシャープなピークを得ることが出
来ることを見い出し、本発明を完成するに至った。即
ち、本発明は、多糖誘導体を有効成分とする分離剤を用
いて液体クロマトグラフィーを行うとき、順相系移動相
中に各種の塩を添加することを特徴とする各種化合物の
液体クロマトグラフィーによる分離法を提供するもので
ある。Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the above-mentioned problems of the conventional liquid chromatography system, and as a result, have found that various types of liquids are contained in the normal-phase mobile phase. By adding a salt, it was possible to improve the separation of a compound that was difficult to separate or a compound that could not be separated, and found that a sharper peak could be obtained, and completed the present invention. . That is, the present invention provides a method for performing liquid chromatography using a separating agent containing a polysaccharide derivative as an active ingredient, by performing liquid chromatography of various compounds characterized by adding various salts to a normal-phase mobile phase. It provides a separation method.
【0005】本発明に用いられる分離剤は多糖誘導体を
有効成分とするものであり、具体的には、特開昭63−60
944 号公報p363 に開示されているもの、即ち、合成多
糖、天然多糖、天然物変成多糖の誘導体が用いられ、好
ましくは高純度の多糖を容易に得ることのできるセルロ
ース、アミロース、β−1,4 −キトサン、キチン、β−
1,4 −マンナン、β−1,4 −キシラン、イヌリン、α−
1,3 −グルカン、β−1,3 −グルカン等の多糖の有する
水酸基上の水素原子の一部あるいは全部、好ましくは85
%以上を他の原子団で置換したものである。これらの中
で最も有効な分離剤の例としてはセルローストリス(4
−メチル)ベンゾエート、セルローストリスフェニルカ
ルバメート等を挙げることができる。[0005] The separating agent used in the present invention contains a polysaccharide derivative as an active ingredient.
No. 944, p 363, namely, synthetic polysaccharides, natural polysaccharides and derivatives of modified natural polysaccharides are used, and preferably, cellulose, amylose, β-1, 4--chitosan, chitin, β-
1,4-mannan, β-1,4-xylan, inulin, α-
Part or all of the hydrogen atoms on the hydroxyl groups of polysaccharides such as 1,3-glucan and β-1,3-glucan, preferably 85
% Or more is replaced with another atomic group. An example of the most effective separating agent among these is cellulose tris (4
-Methyl) benzoate, cellulose trisphenyl carbamate and the like.
【0006】本発明でいう各種塩とは、酸性物質と塩基
性物質の混合物、あるいはブレンステッド酸とブレンス
テッド塩基の組み合わせの場合には、これから水を除い
たものである。酸性物質としては、過塩素酸、ヨウ化水
素酸、カルボン酸(パーフルオロアルカン酸を含む)、
スルホン酸、ホスホン酸、アルキル硫酸、テトラフェニ
ルホウ酸(HBPh4) 、テトラフルオロホウ酸(HBF4)、三フ
ッ化ホウ素(BF3) 、珪フッ素化水素酸(H2SiF6 又はHSiF
5)、BR3 、フェノール類、シアノホルム等が挙げられ、
好ましくはカルボン酸、特にその中でもトリフルオロ酢
酸である。又、塩基性物質としては、すべての一級、二
級又は三級アミン(グアニジン、イミジンを含む)、四
級アンモニウム水酸化物、三級スルホニウム塩水酸化
物、三級オキソニウム水酸化物、四級ホスホニウム水酸
化物、二級ヨードニウム水酸化物等が挙げられ、好まし
くはジエチルアミンである。The various salts referred to in the present invention are those obtained by removing water from a mixture of an acidic substance and a basic substance or, in the case of a combination of a Bronsted acid and a Bronsted base, from water. Acidic substances include perchloric acid, hydroiodic acid, carboxylic acids (including perfluoroalkanoic acids),
Sulfonic acid, phosphonic acid, alkyl sulfate, tetraphenylboric acid (HBPh 4 ), tetrafluoroboric acid (HBF 4 ), boron trifluoride (BF 3 ), hydrosilicofluoric acid (H 2 SiF 6 or HSiF
5 ), BR 3 , phenols, cyanoform and the like,
Preferred are carboxylic acids, especially trifluoroacetic acid. Examples of the basic substance include all primary, secondary and tertiary amines (including guanidine and imidine), quaternary ammonium hydroxide, tertiary sulfonium salt hydroxide, tertiary oxonium hydroxide, and quaternary phosphonium. Hydroxides, secondary iodonium hydroxides and the like can be mentioned, and preferred is diethylamine.
【0007】本発明において、上記の各種塩類を添加す
る順相系の移動相としては、塩が溶解すればいずれのも
のでもよいが、好ましくはヘキサンなどの非極性溶媒と
これと相溶する極性溶媒、好ましくはアルコール類を一
成分あるいは多成分混合した液である。本移動相は他に
保持の強さ、分離の良さを調整するための他成分を含ん
でもよい。ここでいう他成分の中には、上記酸性物質あ
るいは、上記塩基性物質のいずれかの過剰分であっても
よい。本発明の塩の作り方は、上記酸性物質と上記塩基
性物質を混合するものとは限らず、複分解物等いかなる
ものであっても良い。アミン・カルボン酸塩の調製例を
挙げるなら、例えば、メチレンクロライドのような両成
分が溶解しやすい揮発性溶剤中にアミン、カルボン酸の
いずれか揮発しやすい成分をやや過剰に溶解させ、混和
後、揮発性溶剤を蒸発させたのち塩を得ることができ
る。また、特に移動相の液性を中性付近に保つ必要がな
い場合には塩を一担単離する必要はなく、上記酸性物質
と上記塩基性物質の適当量を各々別個に溶離液中に加え
ても良い(但し、ブレンステッド酸、ブレンステッド塩
基の組み合わせの場合には水が副生することはいうまで
もない。)。実際に本発明の移動相を用いる時には、上
記の塩の一種もしくは何種かを、0.001 %(v/v) から飽
和の濃度において溶解した溶液としてカラムに送液す
る。In the present invention, the normal phase mobile phase to which the above-mentioned various salts are added may be any mobile phase as long as the salt can be dissolved. Preferably, a non-polar solvent such as hexane and a polar solvent compatible therewith are used. It is a liquid obtained by mixing a solvent, preferably an alcohol, with one or more components. The mobile phase may further contain other components for adjusting the strength of retention and the good separation. Among the other components mentioned here, any of the above-mentioned acidic substances and the above-mentioned basic substances may be in excess. The method for preparing the salt of the present invention is not limited to mixing the above-mentioned acidic substance and the above-mentioned basic substance, but may be any substance such as a double decomposition product. For example, to prepare an amine carboxylate, for example, a volatile solvent such as methylene chloride, in which both components are easily dissolved, may be dissolved in a slightly excessive amount, either amine or carboxylic acid, and then mixed. After evaporating the volatile solvent, a salt can be obtained. In particular, when it is not necessary to maintain the liquidity of the mobile phase at around neutral, it is not necessary to isolate all the salts, and appropriate amounts of the acidic substance and the basic substance are separately added to the eluate. It may be added (however, it goes without saying that water is by-produced in the case of a combination of a Bronsted acid and a Bronsted base). In practice, when using the mobile phase of the present invention, one or more of the above salts are sent to the column as a solution in which the concentration is from 0.001% (v / v) to saturation.
【0008】[0008]
【作用】本発明の方法により、従来分離が不可能であっ
た化合物の分離を可能にしたが、その作用は、塩状態で
存在するイオン性化合物は、本発明で述べる塩を添加し
た移動相中で、例えば以下の式(1) および(2) のように
イオン交換されクロマトグラフィー分離に最も適したイ
オン対として挙動すること、あるいは添加塩が共役酸(C
+ ) と共役塩基(D- ) の両方を含むため、イオンペア A
- ・ B+ あるいはA- ・ C+ の各陰イオン成分、陽イオ
ン成分いずれに対しても過剰な吸着を防ぐ役割を果たす
こと等によるものと考えられるが明らかではない。The method of the present invention has made it possible to separate compounds which could not be separated by the conventional method, but the effect is that the ionic compound existing in the salt state can be separated from the mobile phase to which the salt described in the present invention is added. Among them, ion-exchanged and behaves as an ion pair most suitable for chromatographic separation as shown in the following formulas (1) and (2), or when the added salt is a conjugate acid (C
+) And conjugate base (D - to include both), ion pair A
- · B + or A - · C each anion component of +, it is considered that mainly due to play a role to prevent even excessive adsorption to any cationic component not clear.
【0009】[0009]
【化1】 Embedded image
【0010】[0010]
【実施例】以下、本発明を実施例及び比較例によって詳
述するが、本発明はこれらの実施例に限定されるもので
はないことは既に述べた理由より明白である。尚、実施
例及び比較例中に用いられるパラメーターk'及びαは以
下のように定義される。EXAMPLES The present invention will be described below in detail with reference to Examples and Comparative Examples. However, it is clear that the present invention is not limited to these Examples for the reasons already described. The parameters k ′ and α used in the examples and comparative examples are defined as follows.
【0011】[0011]
【数1】 (Equation 1)
【0012】実施例1 マレイン酸トリメブチン(トリメブチンのマレイン酸
塩)の光学異性体を、移動相としてヘキサン/2−プロ
パノール=95/5(v/v) に1000ppm のジエチルアミン・
トリフルオロ酢酸塩(以下 DEA・TFA 塩と記す)を添加
した混合液を用いて分離した。そのクロマトグラムを図
1に示し、また両エナンチオマーの保持時間、容量比及
び分離係数を表1に示した。カラムはセルローストリス
(4−メチル)ベンゾエートを分離剤とするCHIRALCEL
OJ(ダイセル化学工業(株)製)を用いた。Example 1 The optical isomer of trimebutine maleate (maleate of trimebutine) was used as a mobile phase in hexane / 2-propanol = 95/5 (v / v) at 1000 ppm of diethylamine.
Separation was performed using a mixed solution to which trifluoroacetate (hereinafter referred to as DEA / TFA salt) was added. The chromatogram is shown in FIG. 1, and the retention time, volume ratio and separation coefficient of both enantiomers are shown in Table 1. The column is CHIRALCEL using cellulose tris (4-methyl) benzoate as the separating agent.
OJ (manufactured by Daicel Chemical Industries, Ltd.) was used.
【0013】比較例1−(1) 実施例1と同じマレイン酸トリメブチンを、移動相とし
てヘキサン/2−プロパノール=95/5(v/v) の混合液
を用いて光学異性体分離した。そのクロマトグラムを図
2に示し、また両エンナチオマーの保持時間、容量比及
び分離係数を表1に示した。尚、固定相には、実施例1
と同じカラムを用いた。Comparative Example 1- (1) The same trimebutine maleate as in Example 1 was subjected to optical isomer separation using a mixed solution of hexane / 2-propanol = 95/5 (v / v) as a mobile phase. The chromatogram is shown in FIG. 2, and the retention time, volume ratio and separation coefficient of both enantiomers are shown in Table 1. Note that the stationary phase was prepared in Example 1
The same column was used.
【0014】比較例1−(2) 実施例1のマレイン酸トリメブチンから単離したトリメ
ブチンを、移動相として比較例1−(1) と同じヘキサン
/2−プロパノール=95/5(v/v) の混合液を用いて光
学異性体分離した。そのクロマトグラムを図3に示し、
また両エンナチオマーの保持時間、容量比及び分離係数
を表1に示した。尚、固定相には実施例1と同じカラム
を用いた。Comparative Example 1- (2) Trimebutine isolated from trimebutine maleate of Example 1 was used as a mobile phase in the same hexane / 2-propanol = 95/5 (v / v) as in Comparative Example 1- (1). Was used to separate optical isomers. The chromatogram is shown in FIG.
Table 1 shows the retention time, volume ratio and separation coefficient of both enantiomers. The same column as in Example 1 was used for the stationary phase.
【0015】[0015]
【表1】 [Table 1]
【0016】実施例2 塩酸ミアンセリン(ミアンセリンの塩酸塩)の光学異性
体を、移動相としてヘキサン/2−プロパノール=95/
5(v/v) に1000ppm の DEA・TFA 塩を添加した混合液を
用いて分離した。そのクロマトグラムを図4に示し、ま
た両エンナチオマーの保持時間、容量比及び分離係数を
表2に示した。カラムはセルローストリス(4−メチ
ル)ベンゾエートを分離剤とするCHIRALCEL OJ(ダイセ
ル化学工業(株)製)を用いた。Example 2 An optical isomer of mianserin hydrochloride (mianserin hydrochloride) was used as a mobile phase in hexane / 2-propanol = 95 /
Separation was carried out using a mixture of 5 (v / v) and 1000 ppm of DEA / TFA salt. The chromatogram is shown in FIG. 4, and the retention time, volume ratio and separation coefficient of both enantiomers are shown in Table 2. The column used was CHIRALCEL OJ (manufactured by Daicel Chemical Industries, Ltd.) using cellulose tris (4-methyl) benzoate as a separating agent.
【0017】比較例2−(1) 実施例2と同じ塩酸ミアンセリンを、移動相としてヘキ
サン/2−プロパノール=95/5(v/v) の混合液を用い
て光学異性体分離した。そのクロマトグラムを図5に示
し、また両エンナチオマーの保持時間、容量比及び分離
係数を表2に示した。尚、固定相には、実施例2と同じ
カラムを用いた。Comparative Example 2- (1) The same mianserin hydrochloride as in Example 2 was subjected to optical isomer separation using a mixed solution of hexane / 2-propanol = 95/5 (v / v) as a mobile phase. The chromatogram is shown in FIG. 5, and the retention time, volume ratio and separation coefficient of both enantiomers are shown in Table 2. The same column as in Example 2 was used for the stationary phase.
【0018】比較例2−(2) 実施例2と同じ塩酸ミアンセリンから単離したミアンセ
リンを、移動相として比較例2−(1) と同じヘキサン/
2−プロパノール=95/5(v/v) の混合液を用いて光学
異性体分離した。そのクロマトグラムを図6に示し、ま
た両エンナチオマーの保持時間、容量比及び分離係数を
表2に示した。尚、固定相には、実施例2及び比較例2
−(1) と同じカラムを用いた。Comparative Example 2- (2) Mianserin isolated from the same mianserin hydrochloride as in Example 2 was used as a mobile phase in the same hexane / methanol as in Comparative Example 2- (1).
Optical isomers were separated using a mixture of 2-propanol = 95/5 (v / v). The chromatogram is shown in FIG. 6, and the retention time, volume ratio and separation coefficient of both enantiomers are shown in Table 2. In addition, the stationary phase includes Example 2 and Comparative Example 2.
-The same column as (1) was used.
【0019】[0019]
【表2】 [Table 2]
【0020】[0020]
【発明の効果】本発明の移動相を用いる方法は、従来、
良い分離を得ることが難しかった強塩基性物質の混合物
あるいはその塩、両性イオン化合物のクロマトグラフィ
ー分離を容易にした。また単なる弱塩基性あるいは弱酸
性物質に対してもそれが塩の形で存在する場合には、従
来は遊離塩基あるいは遊離酸を単離する必要があった
が、本法では、塩のまま分析に供することができる。こ
れらの結果は各種の類似した化合物の混合物、特に光学
異性体の分析、分離操作を簡略化しあるいは従来不可能
であったものを可能にした。The method using the mobile phase of the present invention has been
Chromatographic separation of a mixture of strongly basic substances or salts thereof and zwitterionic compounds, for which it has been difficult to obtain good separation, has been facilitated. In the case where a simple weakly basic or weakly acidic substance is present in the form of a salt, it was conventionally necessary to isolate the free base or free acid. Can be provided. These results have allowed mixtures of various similar compounds, especially those which have been previously impossible or have simplified the analysis and separation of optical isomers.
【図面の簡単な説明】[Brief description of the drawings]
【図1】実施例1の分離結果を示すクロマトグラムであ
る。FIG. 1 is a chromatogram showing a separation result of Example 1.
【図2】比較例1−(1) の分離結果を示すクロマトグラ
ムである。FIG. 2 is a chromatogram showing a separation result of Comparative Example 1- (1).
【図3】比較例1−(2) の分離結果を示すクロマトグラ
ムである。FIG. 3 is a chromatogram showing a separation result of Comparative Example 1- (2).
【図4】実施例2の分離結果を示すクロマトグラムであ
る。FIG. 4 is a chromatogram showing a separation result of Example 2.
【図5】比較例2−(1) の分離結果を示すクロマトグラ
ムである。FIG. 5 is a chromatogram showing the separation results of Comparative Example 2- (1).
【図6】比較例2−(2) の分離結果を示すクロマトグラ
ムである。FIG. 6 is a chromatogram showing the results of separation of Comparative Example 2- (2).
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI G01N 30/88 G01N 30/88 W (58)調査した分野(Int.Cl.7,DB名) G01N 30/26 B01D 15/08 C07B 57/00 340 C07B 63/00 G01N 30/48 G01N 30/88 CA(STN) JICSTファイル(JOIS)──────────────────────────────────────────────────の Continuation of the front page (51) Int.Cl. 7 identification code FI G01N 30/88 G01N 30/88 W (58) Field surveyed (Int.Cl. 7 , DB name) G01N 30/26 B01D 15 / 08 C07B 57/00 340 C07B 63/00 G01N 30/48 G01N 30/88 CA (STN) JICST file (JOIS)
Claims (1)
いて液体クロマトグラフィーを行うとき、順相系移動相
中に各種の塩を添加することを特徴とする各種化合物の
液体クロマトグラフィーによる分離法。When a liquid chromatography is carried out using a separating agent containing a polysaccharide derivative as an active ingredient, various salts are added to a normal-phase mobile phase, and the separation of various compounds is performed by the liquid chromatography. Law.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04001143A JP3124350B2 (en) | 1992-01-08 | 1992-01-08 | Liquid chromatography separation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04001143A JP3124350B2 (en) | 1992-01-08 | 1992-01-08 | Liquid chromatography separation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05180818A JPH05180818A (en) | 1993-07-23 |
| JP3124350B2 true JP3124350B2 (en) | 2001-01-15 |
Family
ID=11493223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP04001143A Expired - Fee Related JP3124350B2 (en) | 1992-01-08 | 1992-01-08 | Liquid chromatography separation method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3124350B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3746315B2 (en) | 1994-07-07 | 2006-02-15 | ダイセル化学工業株式会社 | Separating agent |
| JP2014141410A (en) * | 2009-09-01 | 2014-08-07 | Kaneko Hiroyuki | Method for separating and refining atom-encapsulating fullerene salt using electrolyte-containing mobile phase |
-
1992
- 1992-01-08 JP JP04001143A patent/JP3124350B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05180818A (en) | 1993-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69729182T2 (en) | PROCESS FOR CHROMATOGRAPHIC SEPARATION OF PEPTIDES AND NUCLEINE SOW AND NEW HONEY AFFINITY IONUS EXTRACTERMATRIX | |
| Verleysen et al. | Separation of chiral compounds by capillary electrophoresis | |
| Schill et al. | Chiral separation of cationic drugs on an α1-acid glycoprotein bonded stationary phase | |
| Ward et al. | Chiral separations using the macrocyclic antibiotics: a review | |
| DE4446348A1 (en) | Process for the preparation of an optically pure enantiomer of formoterol | |
| Johansson et al. | Reversed-phase ion-pair chromatography of drugs and related organic compounds | |
| DE69922519T2 (en) | PROCESS FOR PROVIDING HIGH-PURITY HMG-COA REDUCTASE HEMMER | |
| US20100081844A1 (en) | Polycationic organic compounds | |
| Hancock et al. | High-pressure liquid chromatography of peptides and proteins XI. The use of cationic reagents for the analysis of peptides by high-pressure liquid chromatography | |
| Zhou et al. | Preparation and chromatographic evaluation of a chiral stationary phase based on carboxymethyl-β-cyclodextrin for high-performance liquid chromatography | |
| DE60130674T2 (en) | PROCESS FOR THE RACEMAT SEPARATION OF AMINO ACID DERIVATIVES | |
| JP3124350B2 (en) | Liquid chromatography separation method | |
| EP0206792A2 (en) | High performance liquid chromatography mobile phase | |
| JPH03118393A (en) | Method for purification of low molecular weight compound in peptide or pseudopeptide structure | |
| Zief et al. | Selection of the mobile phase for enantiomeric resolution via chiral stationary phase columns | |
| Protti et al. | Co-solvents and mobile phase additives in HPLC | |
| CN112881571A (en) | Chiral detection method of Fmoc-L-Hyp (tbu) -OH and isomers thereof by high performance liquid chromatography | |
| JP2938632B2 (en) | Chromatographic separation method | |
| Ward et al. | Synergistic chiral separations using the glycopeptides ristocetin A and vancomycin | |
| EP0970935B1 (en) | Method of separating optical isomers | |
| Scriba | Recognition Mechanisms of Chiral Selectors: An Overview | |
| JP2000159694A (en) | Optical isomer separation method | |
| DE4317139A1 (en) | Process for the preparative gas-chromatographic enantiomer separation of inhalation anaesthetics (enflurane) on cyclodextrin derivatives in polysiloxane solution | |
| DE19509881B4 (en) | Ovoglycoprotein and the same chromatographic digestion agent | |
| WO2014076199A2 (en) | Method for the purification of a (blood) plasma protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081027 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081027 Year of fee payment: 8 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081027 Year of fee payment: 8 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091027 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091027 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101027 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111027 Year of fee payment: 11 |
|
| LAPS | Cancellation because of no payment of annual fees |